RODEN MATTHEW 4
4 · iTeos Therapeutics, Inc. · Filed Nov 12, 2020
Insider Transaction Report
Form 4
RODEN MATTHEW
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-11-09+33,217→ 0 totalExercise: $26.35Exp: 2030-11-09→ Common Stock (33,217 underlying)
Footnotes (1)
- [F1]This stock option shall vest over 3 years, with 1/3 vesting on November 9, 2021, and thereafter in equal monthly installments over the next 24 months subject to the Reporting Person's continued service as a director through the applicable vesting date.